Veru, Inc. (VERU) PT Raised to $24 at Cantor Fitzgerald
Get Alerts VERU Hot Sheet
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 9
Join SI Premium – FREE
Cantor Fitzgerald analyst Brandon Folkes raised the price target on Veru, Inc. (NASDAQ: VERU) to $24.00 (from $15.00) while maintaining an Overweight rating.
The analyst commented, "Post fiscal 1Q21 earnings, we reiterate our Overweight rating on VERU stock and are raising our 12-month price target to $24, from $15. Our new price target assumes the company is able to move forward a number of its pipeline programs, and the potential for Enobosarm to potentially be a blockbuster breast cancer drug provide upside to the current stock price, and keep us constructive on the stock with a high bar set for our expectations."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BOK Financial (BOKF) PT Raised to $97 at DA Davidson
- First BanCorp (FBP) PT Raised to $21 at Keefe, Bruyette & Woods
- Blue Foundry Bancorp (BLFY) PT Lowered to $8 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Cantor Fitzgerald, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!